SOLAR
A 12-Week, Randomized, Open-Label, 3 Arm Parallel Group, Multicenter, Phase IIIb Study Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin Achieving NCEP ATP III LDL-C Goals in High Risk Subjects With Hypercholesterolaemia in the Managed Care Setting.
Sponsor study identifier
Secondary identifiers
interventional
4,444
0 countries
N/A
Study Start
June 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
September 2004
Actual (reported)The purpose of this study is to compare the efficacy and safety of rosuvastatin with simvastatin and atorvastatin in reducing levels of low density lipoprotein cholesterol in subjects with hypercholesterolaemia
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2004
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2002
Date type not reportedThis date has not been verified as actual or estimated.
September 2004
Actual (reported)March 26, 2008
Actual (reported)April 7, 2008
Actual (reported)Percentage of subjects who achieve low density lipoprotein cholesterol goals while receiving treatment with rosuvastatin, compared to subjects receiving treatment with simvastatin or atorvastatin.
6 weeks
Percentage changes in other blood lipid levels while receiving treatment with rosuvastatin, compared to subjects receiving treatment with simvastatin or atorvastatin
6 & 12 weeks
Safety: adverse events & abnormal laboratory markers
6 & 12 weeks
Rosuvastatin
Simvastatin
Atorvastatin
Alex Gold, MD
AstraZeneca
Russell Esterline
AstraZeneca
4,444 participants (actual enrollment reported by the registry).
First Submitted
March 26, 2008
First Posted
April 7, 2008
Study Start
June 2002
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
September 2004
Actual (reported)Last Updated
March 16, 2009
Record last verified: 2009-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: